Click here to take the CME Evaluation and Post-Meeting Survey
Dr. Angélica Cifuentes Kottkamp is a South American doctor who graduated in 2011 from San Martín University, in Bogotá D.C., Colombia. She came to the United States in 2012 to work as a Research Assistant at the Glomerular Center of Columbia University where she oversaw multiple clinical trials on glomerular diseases and kidney transplant. She completed her residency in Internal Medicine in BronxCare Health System, an affiliated hospital of Icahn School of Medicine, and in 2016 she joined NY U Grossman School of Medicine where she completed her Fellowship in Infectious Diseases and Immunology. She joined the Division as Faculty in 2018 and became a key member of the Infectious Diseases team in Bellevue Hospital where she keeps a continuity clinic at the Virology Clinic taking care of patients living with HIV, mostly Hispanics / Latinx. Dr. Kottkamp has led basic science research projects on viruses such as Zika and Chikungunya and has been a major educator in the training of future infectious disease specialists both at NYU and internationally in countries like Zambia & Ghana, achieving important recognition as winning the Teacher of The Year award in 2021. In 2019 she joined the NYU Langone Vaccine Center and has since led multiple vaccine studies of COVID-19, Shingles, Influenza, Monkeypox, monoclonal antibodies, immune responses, among others. During the pandemic, she has been invited to multiple public events on vaccine education for the Latinx community next to important figures such as Dr. Fauci and Dr. David Chokshi (NYC Health Commissioner). Dr. Kottkamp is a member of the Inclusion, Diversity, Equity & Access Committee of the Infectious Diseases Society of America, she is the Associate Director for Research and Diversity of the NYU Langone Vaccine Center and is the Associate Program Director of the Infectious Disease and Immunology Fellowship Training Program at NYU Grossman School of Medicine.
At the completion of this educational session, participants will:
1. Understand different prevention strategies for adults with diverse immunodeficiencies at risk of infectious diseases.
2. Be aware of the differences between vaccine types available and the limitations of vaccine use and efficacy in immunocompromised patients.
3. Know the immunology behind vaccines in the setting of immunocompromised hosts.
4. Appreciate the pipeline, current challenges and future directions in vaccinology.
This CME activity has approved for AMA PRA Category 1 Credit™
for November 16th, 2022 as a live activity. This activity will also be available as an enduring activity from November 23rd, 2022, through November 15th, 2025.
The target audience is all physicians, NPs and PAs involved or interested in HIV education.
This online video and post-activity evaluation are one hour in length.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and the Physicians’ Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.
The Medical Society of the State of New York designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™
. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Policies and standards of the Medical Society of the State of New York and the Accreditation Council for Continuing Medical Education require that speakers and planners for continuing medical education activities disclose any relevant financial relationships they may have with commercial interests whose products, devices, or services may be discussed in the content of a CME activity.
- Dr. James F. Braun, DO (Course Director) has no relevant financial relationships to disclose.
- Dr. William M. Valenti (Moderator) has no relevant financial relationships to disclose.
- Dr. Angélica Cifuentes Kottkamp (Presenter) has had the following personal financial relationships in the past 24 months with manufacturers of the products or services that may be presented in this CME activity: Principal Investigator for Pfizer. Dr. Cifuentes Kottkamp submitted their slides in advance for adequate peer review and will support their presentation and clinical recommendations with the best available evidence from the medical literature. All relevant financial relationships have been mitigated.
This PRN CME activity is funded in part by unrestricted educational grants from:
Click here to take the CME Evaluation and Post-Meeting Evaluation
Gilead Sciences; Janssen Therapeutics, a division of Janssen Products, LP; Merck & Co.; and ViiV Healthcare